Logo

Nanostring Breast Cancer 360 Research Panel

Apr 11, 2018

NanoString Technologies has launched the Breast Cancer 360T (BC 360) research panel, which provides a multimodal analysis of tumor gene expression, microenvironment, and immune response. The 770-gene expression panel is the second in a series of 360 panels, following NanoString's PanCancer Immuno-Oncology 360 panel that was launched last year. It includes content across important breast cancer pathways and validated signatures including NanoString's PAM50 signature for breast cancer subtyping and its Tumor Inflammation Signature, as well as other targets involved in DNA damage repair deficiency, inhibitory immune signaling, and immune cell population abundance.

Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.